What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?

Is there objective evidence demonstrating a benefit of consolidative durvalumab or prophylactic cranial irradiation in patients with stage I small cell lung cancer?

Answer from: Medical Oncologist at Academic Institution

In the ADRIATIC study, stage I or II limited-stage SCLC comprised only about 12% of patients randomized. The point estimate of HR regarding survival benefit was 0.92, with a wide confidence interval exceeding 1.0 (upper range more than 2). I do not recommend durvalumab consolidation for those with s...

Comments

Medical Oncologist at Mary Bird Perkins
What if a patient undergoes surgery and pathologic...

Medical Oncologist at Mercy Health - St. Rita's Medical Center
I would give him adjuvant chemotherapy followed by...

Please select the option that best describes you:

What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?

Related Questions